prolinedithiocarbamate has been researched along with Adenocarcinoma in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (33.33) | 29.6817 |
| 2010's | 1 (8.33) | 24.3611 |
| 2020's | 7 (58.33) | 2.80 |
| Authors | Studies |
|---|---|
| Qin, Y; Sun, W; Wang, Z; Xiang, J; Zhang, F; Zhang, H | 1 |
| Cracolici, V | 1 |
| Leite, V; Nunes Silva, T; Regala, C; Rodrigues, R; Roque, J | 1 |
| Amitani, M; Chino, T; Ito, KI; Ito, T; Kanai, T; Kiyosawa, N; Maeno, K; Morikawa, H; Oba, T; Ono, M; Shimizu, T; Uehara, T | 1 |
| Ha, EJ; Lee, DH; Lee, JH; Moon, J; Roh, J | 1 |
| Assumpção, LVM; Barreto, IS; Etchebehere, ECSC; Laus, AC; Maia, FFR; Moma, CA; Moreno, DA; Reis, RM; Zantut-Wittmann, DE | 1 |
| Landa, I; Leandro-García, LJ | 1 |
| Chen, CY; Chen, WC; Fong, YC; Hsu, SF; Huang, CY; Kao, ST; Li, TM; Liu, SC; Tang, CH; Tsai, FJ | 1 |
| Chen, Y; Gu, KS | 1 |
| Katano, M; Kubo, M; Kuroki, H; Matsumoto, K; Morisaki, T; Nakamura, K; Nakamura, M; Nakashima, H; Tasaki, A; Yamanaka, N | 1 |
| Carthy, CM; Granville, DJ; Hunt, DW; Jolois, O; Matroule, JY; Piette, J | 1 |
| Budanov, AV; Ivanov, AV; Prokhortchouk, AV; Prokhortchouk, EB; Ruzov, AS; Smirnov, AS | 1 |
3 review(s) available for prolinedithiocarbamate and Adenocarcinoma
| Article | Year |
|---|---|
No Longer Well-Differentiated: Diagnostic Criteria and Clinical Importance of Poorly Differentiated/High-Grade Thyroid Carcinoma.
Topics: Adenocarcinoma; Clinical Relevance; Humans; Thyroid Neoplasms | 2023 |
Extremely aggressive course in a poorly differentiated thyroid carcinoma presenting a double mutation of the TERT promoter.
Topics: Adenocarcinoma; Humans; Mutation; Promoter Regions, Genetic; Proto-Oncogene Proteins B-raf; Telomerase; Thyroid Neoplasms | 2023 |
Mechanistic Insights of Thyroid Cancer Progression.
Topics: Adenocarcinoma; Humans; Mutation; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins B-raf; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms | 2023 |
9 other study(ies) available for prolinedithiocarbamate and Adenocarcinoma
| Article | Year |
|---|---|
Newly proposed survival staging system for poorly differentiated thyroid cancer: a SEER-based study.
Topics: Adenocarcinoma; Humans; Neoplasm Staging; Prognosis; Retrospective Studies; Survival Rate; Thyroid Neoplasms | 2023 |
Outcomes of lenvatinib therapy in poorly differentiated thyroid carcinoma.
Topics: Adenocarcinoma; Antineoplastic Agents; Humans; Retrospective Studies; Thyroid Neoplasms | 2023 |
Neutrophil-to-Lymphocyte Ratio Is Associated With the Proportion of Poorly Differentiated Components in Papillary Thyroid Carcinoma.
Topics: Adenocarcinoma; Carcinoma, Papillary; Humans; Lymphocytes; Neutrophils; Prognosis; Retrospective Studies; Thyroid Cancer, Papillary; Thyroid Neoplasms | 2023 |
Contrast-enhanced CT-based Radiomics for the Differentiation of Anaplastic or Poorly Differentiated Thyroid Carcinoma from Differentiated Thyroid Carcinoma: A Pilot Study.
Topics: Adenocarcinoma; Humans; Pilot Projects; Retrospective Studies; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Tomography, X-Ray Computed | 2023 |
Osteopontin increases lung cancer cells migration via activation of the alphavbeta3 integrin/FAK/Akt and NF-kappaB-dependent pathway.
Topics: Adenocarcinoma; Calcium-Calmodulin-Dependent Protein Kinases; Cell Line, Tumor; Cell Movement; Chromones; Flavonoids; Focal Adhesion Kinase 1; Humans; Integrin alphaVbeta3; Lung Neoplasms; Morpholines; NF-kappa B; Oncogene Protein v-akt; Osteopontin; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Proline; Signal Transduction; Thiocarbamates; Tosylphenylalanyl Chloromethyl Ketone | 2009 |
Mechanism of P-glycoprotein expression in the SGC7901 human gastric adenocarcinoma cell line induced by cyclooxygenase-2.
Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Western; Cell Proliferation; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; NF-kappa B; Nitrobenzenes; Paclitaxel; Proline; Signal Transduction; Stomach Neoplasms; Sulfonamides; Thiocarbamates; Tumor Cells, Cultured | 2012 |
Paclitaxel probably enhances cytotoxicity of natural killer cells against breast carcinoma cells by increasing perforin production.
Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Line, Tumor; Cytotoxicity, Immunologic; Female; Humans; Killer Cells, Natural; Membrane Glycoproteins; NF-kappa B; Paclitaxel; Perforin; Pore Forming Cytotoxic Proteins; Proline; Thiocarbamates; Transcription, Genetic | 2005 |
Mechanism of colon cancer cell apoptosis mediated by pyropheophorbide-a methylester photosensitization.
Topics: Acetylcysteine; Adenocarcinoma; Antioxidants; Apoptosis; Caspase 3; Caspases; Ceramides; Chloroquine; Colonic Neoplasms; Cytochrome c Group; Deuterium Oxide; Endoplasmic Reticulum; Gene Expression Regulation, Neoplastic; Golgi Apparatus; Humans; Lysosomes; Mannans; Mannosephosphates; Microscopy, Fluorescence; Mitochondria; NF-kappa B; Oxidation-Reduction; Oxidative Stress; Oxygen; Phosphorylation; Photochemistry; Photosensitizing Agents; Proline; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-bcl-2; Radiation Tolerance; Radiation-Protective Agents; Reactive Oxygen Species; Second Messenger Systems; Singlet Oxygen; Thiocarbamates; Tumor Cells, Cultured | 2001 |
High constitutive level of NF-kappaB is crucial for viability of adenocarcinoma cells.
Topics: Adenocarcinoma; Animals; Apoptosis; Cell Nucleus; Cell Survival; DNA-Binding Proteins; Dose-Response Relationship, Drug; Down-Regulation; Flow Cytometry; Giant Cells; I-kappa B Proteins; Mice; NF-kappa B; NF-KappaB Inhibitor alpha; Proline; Protein Binding; Protein Subunits; Proto-Oncogene Proteins c-myc; Thiocarbamates; Tosylphenylalanyl Chloromethyl Ketone; Transfection; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Tumor Suppressor Protein p53 | 2001 |